Efficacy of Combination Therapy With The JAK Inhibitor Baricitinib In The Treatment of COVID-19

Mostrar otras versiones (1)

BACKGROUND: Coronavirus disease-19 (COVID-19), resulting from infection with SARS-CoV-2, spans a wide spectrum of illness. In severely ill patients, highly elevated serum levels of certain cytokines and considerable cytolytic T cell infiltrates in the lungs have been observed. These same patients ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Thoms, Brendan Lawless, Gosselin, Jeanne, Libman, Bonita, Littenberg, Benjamin, Budd, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437315/
https://www.ncbi.nlm.nih.gov/pubmed/34518834
http://dx.doi.org/10.21203/rs.3.rs-835734/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437315/
https://www.ncbi.nlm.nih.gov/pubmed/34518834
http://dx.doi.org/10.21203/rs.3.rs-835734/v1

Ejemplares similares